| 1 |
Scott J. Prior |
Covidien Lp |
17 |
| 2 |
Avinash Phadke |
Achillion Pharmaceuticals |
6 |
| 2 |
Kailiang Chen |
Butterfly Network |
6 |
| #4 |
Xiangzhu Wang |
Achillion Pharmaceuticals |
4 |
| #4 |
Akihiro Hashimoto |
Achillion Pharmaceuticals |
4 |
| #6 |
Jay Breindel |
Covidien Lp |
3 |
| #6 |
Joseph K. Lane |
Stop River Development |
3 |
| #6 |
Henri Lichenstein |
Ai Therapeutics |
3 |
| #6 |
Bing Ma |
Brown University |
3 |
| #6 |
Peter J. Minter |
Interlock Usa |
3 |
| #11 |
Katherine J. Kayser-Bricker |
Forma Therapeutics |
2 |
| #11 |
Oswald Crasta |
Pioneer (Corteva) |
2 |
| #11 |
Benjamin Cipriany |
Quantum-Si Incorporated |
2 |
| #11 |
Nicholas Maiorino |
Covidien Lp |
2 |
| #11 |
Mark Milgrew |
Thermo Fisher |
2 |
| #11 |
Vincent B. Ciofalo |
Bridge Pharma |
2 |
| #17 |
James A. Miessau |
Immunsys |
1 |
| #17 |
Mehdi Mesri |
Celera |
1 |
| #17 |
Kevin R. Fogarty |
Covidien Lp |
1 |
| #17 |
George Nicholas Loussides |
Sikorsky Aircraft |
1 |
| #17 |
Christopher J. DeBenedictis |
Tangoe |
1 |
| #17 |
Patrick Harewood |
Henkel Ip & Holding Gmbh |
1 |
| #17 |
Mark Waclawiak |
— |
1 |
| #17 |
Julian Pino |
— |
1 |
| #17 |
Douglas L. Sheridan |
Alexion Pharmaceuticals |
1 |
| #17 |
Robert Dally |
Eli Lilly |
1 |
| #17 |
Alexander Tikhonov |
Azitra |
1 |
| #17 |
Alisa K. Waterman |
BOE |
1 |
| #17 |
Thomas J. Moscarillo |
— |
1 |
| #17 |
Stéphane De Lombaert |
Neurogen |
1 |
| #17 |
Cedo Martin Bagi |
Zoetis Services |
1 |
| #17 |
Hans Almqvist |
Createc |
1 |
| #17 |
Seth J. Boutin |
Hartford Fire Insurance |
1 |
| #17 |
Christopher J. Criscuolo |
Covidien Lp |
1 |
| #17 |
Craig M. Whitehouse |
Analytica Of Branford |
1 |
| #17 |
Hur Koser |
Ancera |
1 |
| #17 |
Seth Gleiman |
Covidien Lp |
1 |
| #17 |
Themistoclis Kyriakides |
Yale University |
1 |
| #17 |
Steven M. Lefkowitz |
Agilent Technologies |
1 |
| #17 |
Michael Jeffrey Brookman |
Averill Partners |
1 |
| #17 |
Robert I. White, Jr. |
Cook Medical Technologies |
1 |
| #17 |
William Henry Dietz |
Hubbell Incorporated |
1 |